Claire Feeney

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 491 citations · Full text

Medicine, Dermatology, Immunology +14

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen et al. · JAMA Dermatology · 2020 · 388 citations · Full text

Medicine, Dermatology, Pharmacology +12

Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration

Gregory Scott, Henrik Zetterberg, Amy Jolly et al. · Brain · 2017 · 228 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis

Lawrence F. Eichenfield, Carsten Flohr, Robert Sidbury et al. · JAMA Dermatology · 2021 · 162 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial

Andrew Blauvelt, Jonathan I. Silverberg, Charles Lynde et al. · Journal of the American Academy of Dermatology · 2021 · 152 citations · Full text

Medicine, Dermatology, Pharmacology +10